CDC Viral Hepatitis Updates: Medscape CDC Expert Commentary - Testing for Hepatitis C: New Guidance
Centers for Disease Control and Prevention (CDC) sent this bulletin at 07/30/2013 01:27 PM EDT
Viral Hepatitis Updates from CDC
Medscape CDC Expert Commentary - Testing for Hepatitis C: New Guidance
Medscape CDC Expert Commentary - Testing for Hepatitis C: New Guidance
This Medscape activity features Chong-Gee Teo, MD, PhD, Laboratory Branch Chief in the Division of Viral Hepatitis at CDC. Dr. Teo discusses CDC’s updated guidance for clinicians and laboratorians for testing for hepatitis C virus (HCV) infection. Testing for hepatitis C should be initiated with a test for antibody to HCV, and all reactive results should be followed by a test for HCV RNA. The bottom line - HCV testing must ensure the identification of persons with current HCV infection. If you do not already have a Medscape account, you will need to sign up by providing your name, email address and profession. http://www.medscape.com/viewarticle/808327
MMWR: Investigation of Hepatitis E Outbreak Among Refugees - Upper Nile, South Sudan, 2012-2013As of January 27, 2013, a total of 5,080 acute jaundice syndrome (AJS) cases had been reported from all four Maban County refugee camps (Doro, Gendrassa, Jamam, and Yusuf Batil). Hepatitis E virus (HEV) infection was confirmed in a convenience sample of cases in each camp. A cross-sectional serosurvey conducted in Jamam camp in November 2012 indicated that 54.3% of the population was susceptible to HEV infection. Across all camps, an AJS case-fatality rate (CFR) of 10.4% was observed among pregnant women. The outbreak response has focused on improving safe drinking water availability, improving sanitation and hygiene, conducting active case finding, and optimizing clinical care, especially among pregnant women.http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6229a2.htm
MMWR: Hepatitis B Vaccine Birthdose Practices in a Country Where Hepatitis B is Endemic - Laos, December 2011–February 2012Chronic hepatitis B virus (HBV) infection causes approximately 325,000 deaths from cirrhosis and liver cancer each year in the Western Pacific Region of the World Health Organization (WHO). With an estimated infection prevalence of >8%, HBV is considered highly endemic in Laos and is most commonly transmitted from mother to child during birth and early childhood. A hepatitis B vaccine birth dose is needed to prevent mother-to-child HBV transmission. Health facilities can help prevent mother-to-child HBV transmission in Laos by ensuring vaccine availability, vaccinating all infants born in the facility, and enhancing outreach services for home births.http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6229a3.htm
.png)
No hay comentarios:
Publicar un comentario